IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.158
EU - Europa 3.606
AS - Asia 2.279
SA - Sud America 176
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 10.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.118
SG - Singapore 889
CN - Cina 712
IT - Italia 706
IE - Irlanda 674
SE - Svezia 515
UA - Ucraina 510
TR - Turchia 352
GB - Regno Unito 293
DE - Germania 255
FR - Francia 223
BR - Brasile 166
FI - Finlandia 161
IN - India 133
RU - Federazione Russa 114
KR - Corea 86
AT - Austria 37
HK - Hong Kong 36
VN - Vietnam 33
CA - Canada 27
NL - Olanda 27
BE - Belgio 18
CZ - Repubblica Ceca 16
RO - Romania 13
CH - Svizzera 8
MX - Messico 8
ES - Italia 5
LT - Lituania 5
PL - Polonia 5
TW - Taiwan 5
AR - Argentina 4
BD - Bangladesh 4
EU - Europa 4
HR - Croazia 4
IL - Israele 4
AZ - Azerbaigian 3
EC - Ecuador 3
EE - Estonia 3
AU - Australia 2
BG - Bulgaria 2
HU - Ungheria 2
ID - Indonesia 2
IQ - Iraq 2
IR - Iran 2
JP - Giappone 2
LV - Lettonia 2
MA - Marocco 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GT - Guatemala 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
QA - Qatar 1
TH - Thailandia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 10.233
Salva come PNG Salva come JPEG
Città #
Chandler 780
Jacksonville 696
Dublin 657
Singapore 610
Princeton 318
Southend 244
Nanjing 215
Izmir 195
Ashburn 177
The Dalles 166
Altamura 141
Santa Clara 134
Chieti 111
Dearborn 108
Beijing 105
Wilmington 104
Cambridge 97
Ann Arbor 87
Boardman 74
Nanchang 65
Pescara 56
Los Angeles 48
Helsinki 43
New York 37
Shenyang 37
Munich 36
Hong Kong 35
Rome 35
Nuremberg 33
Pune 32
Dong Ket 30
Tianjin 28
Hebei 27
Seattle 27
Washington 27
Jiaxing 25
Kunming 24
Woodbridge 24
Milan 21
Changsha 20
Hangzhou 20
Dallas 18
Brussels 17
Grevenbroich 16
Norwalk 16
Jinan 14
São Paulo 14
Toronto 14
Changchun 13
Espoo 13
Frankfurt am Main 13
Augusta 12
Moscow 12
Vienna 12
Brno 11
Falls Church 9
Turku 9
Brooklyn 8
Guangzhou 8
Lanzhou 8
Lappeenranta 8
London 8
Orange 8
San Francisco 8
San Mateo 8
San Vito Chietino 8
Tappahannock 8
Ningbo 7
Edinburgh 6
Houston 6
Lille 6
Rio de Janeiro 6
Ascoli Piceno 5
Bari 5
Chicago 5
Düsseldorf 5
Hefei 5
Mexico City 5
Montreal 5
Porto Alegre 5
Shanghai 5
Taipei 5
Albenga 4
Andover 4
Aquila 4
Auburn Hills 4
Boston 4
Curitiba 4
Hyderabad 4
Leawood 4
Montesilvano 4
Olomouc 4
Pianella 4
Putignano 4
Salvador 4
Atlanta 3
Baku 3
Belo Horizonte 3
Chengdu 3
Francavilla Al Mare 3
Totale 6.190
Salva come PNG Salva come JPEG
Nome #
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 121
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 116
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 112
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 109
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 107
Relevance of plant lectins in human cell biology and immunology 107
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 104
Metabolic modifications in HIV-infected women 102
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 102
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 101
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 99
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 98
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 98
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 97
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 97
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 96
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 95
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 94
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 94
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 93
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 89
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 89
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 88
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 88
Acute urinary retention due to HSV-1: a case report 87
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 87
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 87
Canakinumab in a subgroup of patients with COVID-19 86
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 85
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 85
IL-1beta induces alkaline phosphatase in human phagocytes 84
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 83
Inguinal lymphadenopathy due to Bartonella henselae 82
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 82
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 82
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 82
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 82
Is the rate of virological failure to cART continuing to decline in recent calendar years? 81
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 81
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 80
Proteinuria in an African HIV-infected patient: effects of telmisartan. 79
Antiretroviral therapy management and rationalisation of available resources 79
Normal breathing releases SARS-CoV-2 into the air 79
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 78
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 77
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 77
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 77
Hypertension in HIV: Management and Treatment 76
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 76
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 75
High dose of erythropoietin in management of interferon/ribavirin induced anemia 75
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 75
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 75
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 74
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 74
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 74
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 73
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 73
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 73
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 73
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 72
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 72
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 72
Periodontitis and cytokine patterns in HIV positive patients 71
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 71
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 71
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 70
Interleukin-31: a new cytokine involved in inflammation of the skin 70
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 70
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 70
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 70
Probiotics and anti-inflammatory processes in HIV infection: from Benchside Research to Bedside 70
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 69
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 69
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 68
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 68
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 67
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 67
IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances 66
Ruolo delle citochine nella patogenesi delle malattie infettive 66
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 66
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 66
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 66
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 66
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 66
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 66
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 65
Infected atrial mixoma: a rare cause of fever 64
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 64
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 64
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 63
Esophagitis and anticonvulsant hypersensitivity syndrome. 63
Associations between immune depression and cardiovascular events in HIV infection. 63
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 63
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 63
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008. 62
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. 62
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 61
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 61
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/m 61
Totale 7.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020199 0 0 0 0 0 0 0 0 0 0 173 26
2020/2021859 122 6 153 18 73 170 33 24 57 82 52 69
2021/2022773 27 24 11 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/20252.382 187 528 383 112 60 134 97 183 267 209 222 0
Totale 11.018